Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
63 Cards in this Set
- Front
- Back
3 Characteristics of the endocrine system
|
1. ductless
2. Hormones secreted > interstitial space > into the blood 3. No anatomic connections among endocrine organs |
|
2 roles of homeostasis of the endocrine system
|
1. Coordinates and integrates cellular activity
2. Inter-relationship of chemical messengers |
|
What is the role of target organs in the endocrine system
|
- hormones bind to receptors on cells of target organs
- biologic response results |
|
3 structures that make-up hormones of the endocrine system
|
1. Proteins (peptides)
2. Steroids 3. Amino acid derivatives (amines) |
|
make-up of protein (peptide) hormones & ex. of peptide hormones
|
- most hormones
- contain CHO & so are glycoproteins - synthesized on endoplasmic reticulum of endocrine cells then transferred to Golgi apparatus for packaging into secretory vesicles - Ex. Insulin, ACTH, Glucagon, TSH |
|
Make-up of Steroid hormones & ex.
|
- derived from Cholesterol
- usually not stored - Ex. Cortisol, Aldosterone |
|
Make-up of Amino acid derivative hormones (amines) & ex
|
- synthesized from amino acid tyrosine
- include catecholamines - Ex. Catecholamines, Thyroid hormones - thyroxine & epi have similar cardiac effects as catecholamines |
|
Neurotransmitters
|
released by axons into synapse (ANS)
|
|
Endocrine (telecrine)
|
released into circulation then travels to target via the blood
|
|
Neuroedocrine
|
secreted by neurons into circulation influencing cellular fxn at another location
|
|
Paracrine
|
hormone is released from 1 cell & produces effect on a neighboring cell of a different type often in the same organ via interstitial space
|
|
Autocrine
|
hormone produces effect on the same cell that released it
|
|
Cytokines
|
peptides secreted by cells into the ECF which can fxn as autocrines, paracrines, or endocrine hormones.... i.e. interlukens
|
|
describe how Peptides & Catecholamines are transported
|
water soluble hormones dissolved in plasma & transported to traget tissue via the interstitial space
|
|
describe how Steroids & Thyroid hormones are transported
|
plasma protein bound such that less than 10% of hormone is free in solution; reservoir
|
|
Metabolic Clearance rate
|
rate of disappearance of hormone from the plasma/concentration of hormone per mL plasma
|
|
4 ways clearance of hormones occurs
|
1. metabolic destruction by tissues
2. binding with tissues 3. excretion into bile by the liver 4. excretion into the urine by the kidneys |
|
3 receptor locations
|
1. cell membrane surface
2. cytoplasm 3. cell nucleus |
|
hormones where the target receptor is on the cell membrane surface
|
1. Proteins
2. Peptides 3. catecholamines |
|
hormone where the target receptor is on the cytoplasm
|
Steroid
|
|
hormones where the target receptor is on the cell nucleus
|
1. thyroid hormone receptor
2. chromosomes assoc. |
|
the ultimate fxn of the endocrine and neuroendocrine system
|
adapt to changing environments and maintaining homeostasis
|
|
(ex of) Negative feedback in the endocrine system
|
Tropic hormone (TSH) stimulates the release of another hormone (thyroid hormone) > negative feedback on the anterior pituitary > inhibition of further release of TSH
|
|
(ex of) Positive feedback
|
Lutenizing hormone from stimulation of estrogen on anterior pituitary > lutenizing hormone act on ovaries to stimulate increased secretion of estrogen > increased LH and when appropriate levels are achieved negative feedback takes place
|
|
what is Neuro-control of hormones
|
it relates to the neuro & endocrine system and neuro-transmitters are mediators of neuro-control
|
|
Role of Pancrease
|
- central role in digestion and in metabolism, utilization, & storage of energy substrates
|
|
2 major tissue types in the pancrease
|
1. Acini (lobules)
2. Islets of Langerhans |
|
describe Acini (lobules) tissue type of pancrease
|
divided by connective tissue & connected to a duct (exocrine) > pancrease duct > duodenum
- ex. amilase secretion into duodenum |
|
describe the Islets of Langerhans of the pancrease
|
- cluster of endocrine cells
- 0.3mm diameter arranged around capillary (highly vascularized) - embedded within Acini - b/c islet cells are very vascular it makes it easy for hormones that get secreted by islet cells to go into interstitial space & into the circulation |
|
resting muscle membrane only slightly permeable to glucose in absence of insulin except: (3 ways)
|
1. moderate-heavy exercise causes contraction which makes fivers more permeable to glucose
2. following a meal with blood glucose levels high and lrg amounts of insuling secreted there is rapid transport of glucose and preferential use of glucose by the muscle fibers so increases the rate of glucose transport by 15 times 3. glucose is then stored in the liver as glycogen and when bld sugar drops between meals the liver glycogen gets put back into glucose |
|
4 things follow glucose ingestion that are the effects of insulin on CHO metabolism
|
1. insulin secreted inactivates liver phosphorylase
2. insulin enhances glucose uptake from blood and liver by increasing glucokinase activity 3. insulin increase activity of enzymes leading to glycogen synthesis: inhibit glycogenolosis 4. net result; glycogen can increase to a total of 5-6% of the liver mass or 100g of stored glycogen |
|
5 effects on decreased blood glucose
|
1. decrease insulin secretion by beta cells with low bld gluc
2. glycogen synthesis stops 3. glycogen is spit into glucose with activation of phosphorylase=glycogenolosis 4. glucose phospates now activated by lack of insulin removing the phosphate radical from glucose 5. glucose diffuses back into the blood |
|
major fxn of insulin and it's secondary fxn
|
increases the rate of glucose transport into the resting muscle cell by 15 times
Secondary fxn: promotes uptake, storage, and use of glucose by the liver |
|
Primary target of insulin
|
skeletal muscle
|
|
where is insulin synthesized?
|
beta cells
|
|
what happens with inhibition of gluconeogenesis?
|
1. decreased amt & activity of liver enzymes
2. decreased release of amino acids from muscle and other tissues |
|
what is the only substrate the brain can used for energy
|
glucose
brain cells can use glucose w/o insulin being present |
|
4 CNS symptoms that develop when glucose levels drop below 50mg/100mL
|
1. Irritability
2. Syncope 3. Seizures 4. Coma |
|
list the steps how excess glucose becomes fat
|
1. excess glucose
2. Pyruvate 3. acetyl CoA 4. fatty acids 5. triglycerides 6. LDL 7. adipose tissue |
|
what is the end product of fatty acid oxydation in the body if there isn't insulin
|
Aceto-acetic acid
some aceto-acetic acid converts to beta hydroxy-butaric acid and acitone = ketone bodies, causing ketosis and acidosis |
|
5 effects of insulin on protein metabolism
|
1. promotion of protein synthesis and storage
2. Lack of insulin results in protein depletion & increased amino acids in the blood 3. Catabolism of protein results in increased urea excretion (from muscle brk down) 4. protein wasting contributes to muscle weakness and organ dysfxn in DM 5. insulin fxns synergistically with GH to promote growth |
|
What is the rate limiting step for glucose metabolism w/ beta cell
|
Phosphorilation
|
|
Major mechanism for glucose sensing and change in amt of insulin secreted
|
conversion of glucose to glucose-6-phosphate
|
|
factors that increase insulin secretion
|
1. increased blood glucose
2. increased blood free fatty acids 3. increased blood amino acids 4. GI hormones (gastrin, secretin, gastric inhib peptide etc) 5. glucagon, GH, cortisol 6. parasympathetic stimulaion: Ach 7. B-adrenergic stimulation 8. insulin resistance (obesity) 9. sulfonylurea drugs (glyburide, tolbutamide) |
|
factors that decrease insulin secretion
|
1. decreased blood glucose
2. fasting 3. somatostatin 4. alpha-adrenergic activity 5. Leptin |
|
how long does it take inulin secretion to decrease when glucose levels fall
|
3-5min
|
|
What is Glucagon?
What secretes it? What is its role? What is its target organ? What is it inhibited by? |
1. Glucagon is a polypeptide hormone
2. Secreted by the Alpha cells of the pancrease 3. It increases blood glucose concentrations; Brks glycogen down into glucose; opposes insulin; makes glucose from non-CHO sources (amino acids and fats) 4. Glucagon's target organ is the liver 5. inhibited by hyperglycemia |
|
What is Somatostatin and what does it do?
What secretes it? What stimulates its secretion? What is its role? |
1. Polypeptide that causes decreased secretion of insulin and glucagon, decreases GI motility, and decreases secretion and absorption in the GI tract
2. It is secreted by the Beta Cells of the illetes 3. Secretion is stimulated by increased blood glucose, amino acids, fatty acids, and GI hormones 4. It's role: increase the length of time food is in GI tract and prevent rapid exhaustion of food nutrients (chemically identical to GH inhibitory hormone) |
|
What inhibits the secretion of Somatostatin
|
1. decreased secretion of insulin and glucagon
2. decreased GI motility 3. decreased secretion and absorption in GI tract |
|
3 organs where glucose is the only nutrient normally used
|
1. Brain
2. Retina 3. Germinal epithelium of the gonads |
|
What is Type 1 DM?
|
Syndrome of impaired metabolism of CHO, fats, and protein.
Impaired entry of glucose into cells causing increased levels in the blood d/t no insulin and beta cell destruction |
|
Signs and Symptoms of Type 1 DM
|
1. increased BS
2. increased fat utilization 3. protein depletion 4. polydipsia, polyuria, and polyphagia |
|
Describe what happens in the dehydrated type 1 DM
|
1. increased plasma osmolarity
2. increased glucose in urine 3. increased water and NA loss - cellular starvation stimulates hunger, stimulating compensatory response to increased release and avail. of fuel substrates (fat and protein) |
|
What is the threshold for glucose to spill into urine
|
plasma levels of greater than or equal to 180mg/dL glucose
|
|
What is the sequellae of chronically high BS levels in Type 1 DM?
|
1. bld vessel abnormalities
2. increased risk for MI, CVA, ESRD, retinopathy, & PVD 3. Neuropathy: peripheral & autonomic 4. increased fat utilization: metabolic acidosis 5. tissue/muscle wasting |
|
Patho of Type 2 DM
|
- insulin resistance secondary to abnormal signaling linking receptor activation with cellular effects
- compensatory increased insulin secretion - metabolic syndrom (syndrome X) - inadequate response of beta cells to glucose levels result in decreased mass of beta cells - decreased response of peripheral tissue to insulin - cannot increase insulin production after meals |
|
Type 2 DM may be d/t:
|
1. problem with glucose transport
2. abnormal insulin synthesis 3. abnormal insulin processing 4. abnormal insulin storage 5. abnormal insulin secretion |
|
Hgb A1C
|
the Hgb at which glucose is bound
- most accurate measure of long term control and effectiveness of tx -avg blood sugar over 2-3months b/c lifespan of RBC = 120 days. Non-DM < 6% goal of therapy < 7.5% |
|
Signs and symptom of DKA
Goal in BS correction |
1. dyspnea
2. hyperventilation 3. n/v 4. abdominal pain 5. change in sensorium - Goal to drop BS = decrease by 75-100mg/dL/hr or 10% per hr - 10 units insulin/hr or 0.1units/kg/hr |
|
Hyperosmolar NonKetotic Syndrome
|
Osmotic diuresis d/t increased blood sugar causing dehydration and hyperosmolar situation
|
|
What is the diabetic complication associated with the highest mortality
|
Nephropathy
|
|
d/t to diabetic neuropathies you may see what pathophysiologic abnormalities
|
1. resting tachycardia
2. low BP or labile BP 3. decreased or absent beat to beat variability 4. may not respond normally to atropine 5. HTN 6. neurogenic bladder 7. absence of sweating 8. gastroporesis (20-30%) |
|
What are some vascular anomalies associated with DM
|
1. CAD
2. Cerebral vascular dx 3. PVD 4. Retinopathy 5. Neuropathy 6. Stiff joint syndrome (30-40%) |